Key result
Calpain inhibition reduces myocardial injury and suppresses necroptosis in viral myocarditis models.
Why the study?
The mechanisms governing necroptosis during Coxsackievirus B3-induced myocarditis remain unclear despite its contribution to disease progression.
Does calpain inhibition attenuate Coxsackievirus B3-induced myocarditis in murine models?
Does calpain inhibition attenuate Coxsackievirus B3-induced myocarditis in murine models?
p-value: p=<0.01
Calpain inhibition attenuates Coxsackievirus B3-induced myocardial injury by suppressing the RIPK1/RIPK3/MLKL necroptosis pathway in preclinical models.
May attenuate injury in CVB3 myocarditis models; leaves open clinical translation of necroptosis pathway targeting.
Viral myocarditis caused by CVB3 inflicts substantial myocardial damage and predisposes to heart failure. Although necroptosis contributes to disease progression, the mechanisms governing this death pathway during CVB3 infection remain unclear. We found that calpain and its inhibitor Cast were dynamically expressed during CVB3 infection, correlating with cardiac damage, inflammation, and fibrosis. Further investigation revealed that CVB3 dynamically induced cardiomyocyte necroptosis by activating the RIPK1/RIPK3/MLKL pathway, which was prominently activated in the early acute phase but potentially attenuated in later stages. Immunofluorescence analysis supported the translocation of p-MLKL from the nucleus to the plasma membrane during disease progression. Importantly, both in vivo and in vitro experiments supported that calpain inhibition ALLN attenuated VMC via the RIPK1/RIPK3/MLKL pathway, and improved cardiac function post-CVB3 infection. The calpain activator PMMA exacerbated this process. Our findings reveal that calpain inhibition attenuated VMC by modulating the RIPK1/RIPK3/MLKL pathway, uncovering a novel regulatory mechanism in VMC.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied Viral myocarditis (n=24). ALLN (calpain inhibitor) vs. CVB3 infection alone was evaluated on Myocardial injury (cTnI and CK-MB levels) and necroptosis pathway activation (p=<0.01). Calpain inhibition with ALLN significantly reduced myocardial injury markers (cTnI and CK-MB) and attenuated cardiomyocyte necroptosis via the RIPK1/RIPK3/MLKL pathway in CVB3-infected mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: